MR imaging of reperfused myocardial infarction: Comparison of necrosis-specific and intravascular contrast agents in a cat model

Radiology

Volumn 226, Issue 3, 2003, Pages 739-747

  Lee, Seung Soo ^a   Goo, Hyun Woo ^a   Park, Sung Bin ^a   Lim, Chung Hwan ^b   Gong, Gyungyub ^a   Seo, Joon Beom ^a   Lim, Tae Hwan ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Hanseo University   (South Korea)

Author keywords

Animals Contrast media; Contrast media Myocardium; Experimental studies Magnetic resonance (MR); Infarction; MR; Myocardium

Indexed keywords

BIS GADOLINIUM MESOPORPHYRIN; CONTRAST MEDIUM; GADOMER 17; GADOPHRIN 2; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLAND ALTMAN ANALYSIS; CAT; CELL ULTRASTRUCTURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART RATE; HISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LINEAR REGRESSION ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TISSUE NECROSIS; TRANSMISSION ELECTRON MICROSCOPY;

ANALYSIS OF VARIANCE; ANIMALS; CATS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; GADOLINIUM; INJECTIONS, INTRAVENOUS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; METALLOPORPHYRINS; MICROSCOPY, ELECTRON; MYOCARDIAL INFARCTION; NECROSIS;

EID: 0037373406     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2263011473     Document Type: Article

References (35)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66:1146-1149.
2. Ellis SG, Henschke CI, Sandor T, Wynne J, Braunwald E, Kloner RA. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1983; 1:1047-1055.
3. Saeed M, Wendland MF, Masui T, et al. Myocardial infarction: assessment with an intravascular MR contrast medium. Radiology 1991; 180:153-160.
4. Choi SI, Choi SH, Kim ST, et al. Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model. Radiology 2000; 215:863-868.
5. McNamara MT, Higgins CB, Ehman RL, Revel D, Sievers R, Brasch RC. Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA. Radiology 1984; 153:157-163.
6. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100:1992-2002.
7. Pislaru SV, Ni Y, Pislaru C, et al. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 1999; 99:690-696.
8. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94:3318-3326.
9. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Circulation 1995; 92:1117-1125.
10. Kroft LJ, de Roos A. Blood pool contrast agents for cardiovascular MR imaging. J Magn Reson Imaging 1999; 10:395-403.
11. Roberts HC, Saeed M, Roberts TPL, Muhler A, Brasch RC. MRI of acute myocardial ischemia: comparing a new contrast agent, Gd-DTPA-24-cascade-polymer, with Gd-DTPA. J Magn Reson Imaging 1999; 9:204-208.
12. Dong Q, Hurst DR, Weinmann HJ, Chenevert TL, Londy FJ, Prince MR. Magnetic resonance angiography with gadomer-17: an animal study original investigation. Invest Radiol 1998; 33:699-708.
13. Panting JR, Taylor AM, Gatehouse PD, et al. First-pass myocardial perfusion imaging and equilibrium signal change using the intravascular contrast agent NC100150 injection. J Magn Reson Imaging 1999; 10:404-410.
14. Clarke SE, Weinmann HJ, Dai E, Lucas AR, Rutt BK. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. RadioIogy 2000; 214:787-794.
15. Li D, Zheng J, Weinmann HJ. Contrastenhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. Radiology 2001; 218:670-678.
16. Ni Y, Marchal G, Yu J, et al. Localization of metalloporphyrin-induced specific enhancement in experimental liver tumors: comparison of MRI, microangiographic, and histologic findings. Acad Radiol 1995; 2:687-699.
17. Hofmann B, Bogdanov A Jr, Marecos E, Elbert W, Semmler W, Weissleder R. Mechanism of gadophrin-2 accumulation in tumor necrosis. J Magn Reson Imaging 1999; 9:336-341.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 8:307-310.
19. Jennings RB, Steenberger C, Reiner KA. Myocardial ischemia and reperfusion. In: Schien FJ, Gimbrone MA, eds. Cardiovascular pathology. Baltimore, Md: Williams & Wilkins, 1995; 58-64.
20. Oksendal AN, Hals PA. Biodistribution and toxicity of MR imaging contrast media. J Magn Reson Imaging 1993; 3:157-165.
21. Lim TH, Lee JH, Lee TK, Mun CW. Comparison of gadolinium polylysine and gadopentetate in contrast enhanced MR imaging of myocardial ischemia-reperfusion in cats. J Kor Radiol Soc 1995; 33:59-65.
22. Lim TH, Lee DH, Kim YH, et al. Occlusive and reperfused myocardial infarction: detection by using MR imaging with gadolinium polylysine enhancement. Radiology 1993; 189:765-768.
23. Choi SH, Jiang CZ, Lee TK, et al. Myocardial assessment during subacute stage after ischemia-reperfusion: Gd-DTPA-polylysine enhanced MR imaging in cats. J Kor Radiol Soc 1998; 39:1069-1073.
24. Lim TH, Lee JH, Gong GY, Park SJ, Lee IC. Significance of magnetic resonance signal enhancement in evaluation of myocardial infarction in cats. Invest Radiol 1995; 30:306-314.
25. Saeed M, van Dijke CF, Mann JS, et al. Histologic conformation of microvascular permeability to macromolecular MR contrast medium in reperfused myocardial infarction. J Magn Reson Imaging 1998; 8:561-567.
26. Schiffmann E. Leukocyte chemotaxis. Annu Rev Physiol 1982; 44:553-568.
27. Snyderman R, Goetzl E. Molecular and cellular mechanisms of leukocyte chemotaxis. Science 1981; 213:830-837.
28. Choi SH, Lee SS, Choi SI, et al. Occlusive myocardial infarction: investigation of bis-gadolinium-mesoporphyrins- enhanced T1-weighted MR imaging in a cat model. Radiology 2001; 220:436-440.
29. Bouchard A, Reeves RC, Cranney G, Bishop SP, Pohost GM. Assessment of myocardial infarct size by means of T2-weighted 1H nuclear magnetic resonance imaging. Am Heart J 1989; 117:281-289.
30. Choi SI, Jiang CZ, Lim KH, et al. Application of breath-hold T2-weighted, firstpass perfusion and gadolinium-enhanced TI-weighted MR imaging for assessment of myocardial viability in a pig model. J Magn Reson Imaging 2000; 11:476-480.
31. Arheden H, Saeed M, Higgins CB, et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 2000; 215:520-528.
32. Diesbourg LD, Prato FS, Wisenberg G, et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992; 23:239-253.
33. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995; 92:1902-1910.
34. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218:215-223.
35. Saeed M, Bremerich J, Wendland MF, Wyttenbach R, Weinmann H, Higgins CB. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology 1999; 213:247-257.